Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase III Clinical Trial for Mucosal or Mucocutaneous Leishmaniasis. Comparison Between the Standard and Alternative Antimonial Schemes

NCT01301937 is registered in ClinicalTrials.gov with Oswaldo Cruz Foundation as lead sponsor.

NCT NCT01301937
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01301937 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase III Clinical Trial for Mucosal or Mucocutaneous Leishmaniasis. Comparison Between the Standard and Alternative Antimonial Schemes
Lead sponsor
Oswaldo Cruz Foundation
Phase
Phase 2/3
Overall status
Unknown status
Start date
October 31, 2008
Completion date
December 31, 2021
Enrollment
76 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

mucocutaneous leishmaniasis, mucosal leishmaniasis